Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
12.80%
↑ 100% above average
Average (11q)
-9483.82%
Historical baseline
Range
High:99.86%
Low:-113787.19%
Volatility
-1200.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 12.80% |
| Q2 2025 | 6.32% |
| Q1 2025 | -15.51% |
| Q4 2024 | -5.86% |
| Q3 2024 | -15.96% |
| Q2 2024 | -113787.19% |
| Q1 2024 | 99.86% |
| Q4 2023 | -31.29% |
| Q3 2023 | -22.40% |
| Q2 2023 | -16.23% |
| Q1 2023 | -30.43% |
| Q4 2022 | 0.00% |